FDA approves new weight loss pill, joining injectables in the fight against obesity
December 27, 2025
16,824
1,010
64
6.38%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Npr Episodes Around December 27, 2025
See what was published immediately before and after this episode.
1:25Now PlayingFDA approves new weight loss pill, joining injectables in the fight against obesity
YouTube Description
as posted by the channelFederal regulators have approved a pill version of the popular weight loss drug Wegovy, which is currently only available as an injection. The pills could hit the market by early next year.
Meanwhile, injectable GLP-1 weight loss drugs have transformed obesity care, but they don’t work for everyone.
Roughly half of those who take GLP1s lose 15% or more of their bodyweight, but a minority — about one in six — lose very little. Doctors specializing in obesity care say this is because dozens of factors can contribute to a person’s obesity, and the new class of popular medicines may not address a person’s particular biology.
In few years, though, experts expect genetic and other tests to make it easier to personalize treatments to individual needs.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.